Ta strona została przetłumaczona automatycznie i dokładność tłumaczenia nie jest gwarantowana. Proszę odnieść się do angielska wersja za tekst źródłowy.

Kliniczna ocena bezpieczeństwa i skuteczności systemu NEUROMARK u pacjentów z przewlekłym zapaleniem błony śluzowej nosa (PARAGON)

16 października 2026 zaktualizowane przez: Neurent Medical

Kliniczna ocena bezpieczeństwa i skuteczności systemu NEUROMARK u pacjentów z przewlekłym zapaleniem błony śluzowej nosa (PARAGON) — prospektywne, jednoramienne, wieloośrodkowe badanie kliniczne.

The PARAGON Study is a prospective, single-arm, multicenter safety and efficacy study of the Neurent Medical NEUROMARK System in subjects with chronic rhinitis.

Przegląd badań

Status

Zakończony

Interwencja / Leczenie

Typ studiów

Interwencyjne

Zapisy (Rzeczywisty)

80

Faza

  • Nie dotyczy

Kontakty i lokalizacje

Ta sekcja zawiera dane kontaktowe osób prowadzących badanie oraz informacje o tym, gdzie badanie jest przeprowadzane.

Lokalizacje studiów

    • Alabama
      • Birmingham, Alabama, Stany Zjednoczone, 35242
        • Alabama Nasal and Sinus Center (Alabama Allergy)
    • California
      • California City, California, Stany Zjednoczone, 95661
        • Sacramento ENT
      • Temecula, California, Stany Zjednoczone, 92592
        • United Medical Doctors
    • Colorado
      • Colorado Springs, Colorado, Stany Zjednoczone, 80923
        • Colorado ENT
    • Louisiana
      • Marrero, Louisiana, Stany Zjednoczone, 70072
        • New Orleans Sinus Center
    • Maryland
      • Baltimore, Maryland, Stany Zjednoczone, 21204
        • Centers for Advanced ENT Care (CAdENT)
    • Michigan
      • Royal Oak, Michigan, Stany Zjednoczone, 48073
        • Rontal Clinics
    • Pennsylvania
      • Bethlehem, Pennsylvania, Stany Zjednoczone, 18017
        • Specialty Physician Associates
    • Virginia
      • Richmond, Virginia, Stany Zjednoczone, 23235
        • Richmond ENT
    • Washington
      • Seattle, Washington, Stany Zjednoczone, 98374-1145
        • Ear Nose Throat & Allergy Associates

Kryteria uczestnictwa

Badacze szukają osób, które pasują do określonego opisu, zwanego kryteriami kwalifikacyjnymi. Niektóre przykłady tych kryteriów to ogólny stan zdrowia danej osoby lub wcześniejsze leczenie.

Kryteria kwalifikacji

Wiek uprawniający do nauki

18 lat i starsze (Dorosły, Starszy dorosły)

Akceptuje zdrowych ochotników

Nie

Płeć kwalifikująca się do nauki

Wszystko

Opis

Inclusion Criteria:

Subjects MUST:

  1. Be ≥18 years of age.
  2. Have been experiencing rhinitis symptoms for a minimum of 6 months.
  3. Have moderate to severe symptoms of runny nose (individual rTNSS symptom rating of 2 or 3), mild to severe symptoms of nasal congestion (individual rTNSS symptom rating of 1,2, or 3), and a minimum total score of 5 (out of 12) at baseline.
  4. Have an allergy test (by skin prick or intradermal testing, or by a validated in vitroImmunoglobin E [IgE test]) on file within 5 years of the baseline visit or is willing to have one performed during the study prior to 6-month visit.
  5. Be an appropriate candidate for bilateral NEUROMARK® device treatment performed under local anesthesia.
  6. Test negative for active COVID-19 at the start of the study screening and continue to be free of COVID-19 symptoms until the time of enrollment/treatment.
  7. Be willing and able to comply with all study elements, as indicated by written informed consent.

Exclusion Criteria:

Subjects MUST NOT:

  1. Have clinically significant anatomic obstruction that in the investigator's opinion limit access to the posterior nose, including but not limited to severe septal deviation or perforation, nasal polyps, and/or sinonasal tumor.
  2. Have had previous sinus or nasal surgery within 6 months of study enrollment.
  3. Have previously undergone RF, cryotherapy, or other surgical interventions for rhinitis.
  4. Have an active nasal or sinus infection.
  5. Have nasal mucosal erosion/ulceration.
  6. Have rhinitis symptoms that are due to seasonal allergies only.
  7. Have plans to (or otherwise anticipates the need to) undergo an ENT procedure concurrently or within 6 months after the study procedure.
  8. Have started a new sinonasal medication regimen within 4 weeks prior to treatment that, according to the manufacturer's labelling, has not yet stabilized.
  9. Be on prescribed anticoagulants (eg, warfarin, Plavix) or ≥ 325 mg aspirin that cannot be held for an appropriate time before the procedure.
  10. Have a history of chronic epistaxis or experienced a significant epistaxis event (defined as epistaxis requiring medical intervention) in the past 3 months.
  11. Have numbness of the soft palate, excessive dry eye, excessive dry nose, or other indication of neuro/nerve compromise in the sinonasal cavity.
  12. Have an active rhinitis medicamentosa or a history of rhinitis medicamentosa within the past 6 months.
  13. Have been diagnosed with atrophic rhinitis.
  14. Have had previous head and/or neck irradiation.
  15. Have an allergy or intolerance to local anesthetic agents.
  16. Be pregnant.
  17. Have a physical, neurological, medical, psychiatric condition or situation that, in the investigator's opinion, puts the subject at risk, could confound the study results, or may interfere significantly with the subject's participation in the study.
  18. Be participating in another clinical research study.

Plan studiów

Ta sekcja zawiera szczegółowe informacje na temat planu badania, w tym sposób zaprojektowania badania i jego pomiary.

Jak projektuje się badanie?

Szczegóły projektu

  • Główny cel: Leczenie
  • Przydział: Nie dotyczy
  • Model interwencyjny: Zadanie dla jednej grupy
  • Maskowanie: Brak (otwarta etykieta)

Broń i interwencje

Grupa uczestników / Arm
Interwencja / Leczenie
Eksperymentalny: Treatment

Subjects will undergo treatment with the NEUROMARK System

The NEUROMARK System is indicated for use in otorhinolaryngology (ENT) surgery for creation of radiofrequency (RF) lesions to disrupt posterior nasal nerves in patients with chronic rhinitis.

Co mierzy badanie?

Podstawowe miary wyniku

Miara wyniku
Opis środka
Ramy czasowe
Total rTNSS Score 6M
Ramy czasowe: 6-Month Follow Up

Change in total rTNSS score from baseline at 6-Month Follow up. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. Max score: 12 Min score: 0. Lower values indicate a better outcome. 4 subscales (0-3 score) add together to create total score (out of 12).

6-Month Follow Up
Device- and/or Procedure-related SAEs
Ramy czasowe: 24-Month Follow Up

Number of participants who experienced a device- and/or procedure-related serious adverse event during the course of the study.

24-Month Follow Up

Miary wyników drugorzędnych

Miara wyniku
Opis środka
Ramy czasowe
Total rTNSS Score 1M
Ramy czasowe: 1-Month Follow Up

Change in total rTNSS score from baseline at the 1-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. Max score: 12 Min score: 0. Lower values indicate a better outcome. 4 subscales (0-3 score) add together to create total score (out of 12).

1-Month Follow Up
Total rTNSS Score 3M
Ramy czasowe: 3-Month Follow Up

Change in total rTNSS score from baseline at the 3-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. Max score: 12 Min score: 0. Lower values indicate a better outcome. 4 subscales (0-3 score) add together to create total score (out of 12).

3-Month Follow Up
Total rTNSS Score 9M
Ramy czasowe: 9-Month Follow Up

Change in total rTNSS score from baseline at 9-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. Max score: 12 Min score: 0. Lower values indicate a better outcome. 4 subscales (0-3 score) add together to create total score (out of 12).

9-Month Follow Up
Total rTNSS Score 12M
Ramy czasowe: 12-Month Follow Up

Change in total rTNSS score from baseline at the 12-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. Max score: 12 Min score: 0. Lower values indicate a better outcome. 4 subscales (0-3 score) add together to create total score (out of 12).

12-Month Follow Up
Total rTNSS Score 15M
Ramy czasowe: 15-Month Follow Up

Change in total rTNSS score from baseline at 15-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. Max score: 12 Min score: 0. Lower values indicate a better outcome. 4 subscales (0-3 score) add together to create total score (out of 12).

15-Month Follow Up
Total rTNSS Score 18M
Ramy czasowe: 18-Month Follow Up

Change in total rTNSS score from baseline at 18-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. Max score: 12 Min score: 0. Lower values indicate a better outcome. 4 subscales (0-3 score) add together to create total score (out of 12).

18-Month Follow Up
Total rTNSS Score 21M
Ramy czasowe: 21-Month Follow Up

Change in total rTNSS score from baseline at 21-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. Max score: 12 Min score: 0. Lower values indicate a better outcome. 4 subscales (0-3 score) add together to create total score (out of 12).

21-Month Follow Up
Total rTNSS Score 24M
Ramy czasowe: 24-Month Follow Up

Change in rTNSS score from baseline at the final 24-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. Max score: 12 Min score: 0. Lower values indicate a better outcome. 4 subscales (0-3 score) add together to create total score (out of 12).

24-Month Follow Up
rTNSS Congestion Score 1M
Ramy czasowe: 1-Month Follow Up

Change in rTNSS congestion subscore from baseline at the 1-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Congestion. Max score: 3 Min score: 0. Lower values indicate a better outcome.

1-Month Follow Up
rTNSS Rhinorrhea Score 1M
Ramy czasowe: 1-Month Follow Up

Change in rTNSS rhinorrhea subscore from baseline at the 1-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Rhinorrhea. Max score: 3 Min score: 0. Lower values indicate a better outcome.

1-Month Follow Up
rTNSS Nasal Itching Score 1M
Ramy czasowe: 1-Month Follow Up

Change in rTNSS nasal itching subscore from baseline at the 1-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Nasal Itching. Max score: 3 Min score: 0. Lower values indicate a better outcome.

1-Month Follow Up
rTNSS Sneezing Score 1M
Ramy czasowe: 1-Month Follow Up

Change in rTNSS sneezing subscore from baseline at the 1-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Sneezing. Max score: 3 Min score: 0. Lower values indicate a better outcome.

1-Month Follow Up
rTNSS Congestion Score 3M
Ramy czasowe: 3-Month Follow Up

Change in rTNSS congestion subscore from baseline at the 3-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Congestion. Max score: 3 Min score: 0. Lower values indicate a better outcome.

3-Month Follow Up
rTNSS Rhinorrhea Score 3M
Ramy czasowe: 3-Month Follow Up

Change in rTNSS rhinorrhea subscore from baseline at the 3-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Rhinorrhea. Max score: 3 Min score: 0. Lower values indicate a better outcome.

3-Month Follow Up
rTNSS Nasal Itching Score 3M
Ramy czasowe: 3-Month Follow Up

Change in rTNSS nasal itching subscore from baseline at the 3-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Nasal Itching. Max score: 3 Min score: 0. Lower values indicate a better outcome.

3-Month Follow Up
rTNSS Sneezing Score 3M
Ramy czasowe: 3-Month Follow Up

Change in rTNSS sneezing subscore from baseline at the 3-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Sneezing. Max score: 3 Min score: 0. Lower values indicate a better outcome.

3-Month Follow Up
rTNSS Congestion Score 6M
Ramy czasowe: 6-Month Follow Up

Change in rTNSS congestion subscore from baseline at the 6-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Congestion. Max score: 3 Min score: 0. Lower values indicate a better outcome.

6-Month Follow Up
rTNSS Rhinorrhea Score 6M
Ramy czasowe: 6-Month Follow Up

Change in rTNSS rhinorrhea subscore from baseline at the 6-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Rhinorrhea. Max score: 3 Min score: 0. Lower values indicate a better outcome.

6-Month Follow Up
rTNSS Nasal Itching Score 6M
Ramy czasowe: 6-Month Follow Up

Change in rTNSS nasal itching subscore from baseline at the 6-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Nasal Itching. Max score: 3 Min score: 0. Lower values indicate a better outcome.

6-Month Follow Up
rTNSS Sneezing Score 6M
Ramy czasowe: 6-Month Follow Up

Change in rTNSS sneezing subscore from baseline at the 6-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Sneezing. Max score: 3 Min score: 0. Lower values indicate a better outcome.

6-Month Follow Up
rTNSS Congestion Score 9M
Ramy czasowe: 9-Month Follow Up

Change in rTNSS congestion subscore from baseline at the 9-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Congestion. Max score: 3 Min score: 0. Lower values indicate a better outcome.

9-Month Follow Up
rTNSS Rhinorrhea Score 9M
Ramy czasowe: 9-Month Follow Up

Change in rTNSS rhinorrhea subscore from baseline at the 9-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Rhinorrhea. Max score: 3 Min score: 0. Lower values indicate a better outcome.

9-Month Follow Up
rTNSS Nasal Itching Score 9M
Ramy czasowe: 9-Month Follow Up

Change in rTNSS nasal itching subscore from baseline at the 9-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Nasal Itching. Max score: 3 Min score: 0. Lower values indicate a better outcome.

9-Month Follow Up
rTNSS Sneezing Score 9M
Ramy czasowe: 9-Month Follow Up

Change in rTNSS sneezing subscore from baseline at the 9-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Sneezing. Max score: 3 Min score: 0. Lower values indicate a better outcome.

9-Month Follow Up
rTNSS Congestion Score 12M
Ramy czasowe: 12-Month Follow Up

Change in rTNSS congestion subscore from baseline at the 12-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Congestion. Max score: 3 Min score: 0. Lower values indicate a better outcome.

12-Month Follow Up
rTNSS Rhinorrhea Score 12M
Ramy czasowe: 12-Month Follow Up

Change in rTNSS rhinorrhea subscore from baseline at the 12-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Rhinorrhea. Max score: 3 Min score: 0. Lower values indicate a better outcome.

12-Month Follow Up
rTNSS Nasal Itching Score 12M
Ramy czasowe: 12-Month Follow Up

Change in rTNSS nasal itching subscore from baseline at the 12-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Nasal Itching. Max score: 3 Min score: 0. Lower values indicate a better outcome.

12-Month Follow Up
rTNSS Sneezing Score 12M
Ramy czasowe: 12-Month Follow Up

Change in rTNSS sneezing subscore from baseline at the 12-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Sneezing. Max score: 3 Min score: 0. Lower values indicate a better outcome.

12-Month Follow Up
rTNSS Congestion Score 15M
Ramy czasowe: 15-Month Follow Up

Change in rTNSS congestion subscore from baseline at the 15-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Congestion. Max score: 3 Min score: 0. Lower values indicate a better outcome.

15-Month Follow Up
rTNSS Rhinorrhea Score 15M
Ramy czasowe: 15-Month Follow Up

Change in rTNSS rhinorrhea subscore from baseline at the 15-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Rhinorrhea. Max score: 3 Min score: 0. Lower values indicate a better outcome.

15-Month Follow Up
rTNSS Nasal Itching Score 15M
Ramy czasowe: 15-Month Follow Up

Change in rTNSS nasal itching subscore from baseline at the 15-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Nasal Itching. Max score: 3 Min score: 0. Lower values indicate a better outcome.

15-Month Follow Up
rTNSS Sneezing Score 15M
Ramy czasowe: 15-Month Follow Up

Change in rTNSS sneezing subscore from baseline at the 15-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Sneezing. Max score: 3 Min score: 0. Lower values indicate a better outcome.

15-Month Follow Up
rTNSS Congestion Score 18M
Ramy czasowe: 18-Month Follow Up

Change in rTNSS congestion subscore from baseline at the 18-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Congestion. Max score: 3 Min score: 0. Lower values indicate a better outcome.

18-Month Follow Up
rTNSS Rhinorrhea Score 18M
Ramy czasowe: 18-Month Follow Up

Change in rTNSS rhinorrhea subscore from baseline at the 18-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Rhinorrhea. Max score: 3 Min score: 0. Lower values indicate a better outcome.

18-Month Follow Up
rTNSS Nasal Itching Score 18M
Ramy czasowe: 18-Month Follow Up

Change in rTNSS nasal itching subscore from baseline at the 18-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Nasal Itching. Max score: 3 Min score: 0. Lower values indicate a better outcome.

18-Month Follow Up
rTNSS Sneezing Score 18M
Ramy czasowe: 18-Month Follow Up

Change in rTNSS sneezing subscore from baseline at the 18-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Sneezing. Max score: 3 Min score: 0. Lower values indicate a better outcome.

18-Month Follow Up
rTNSS Congestion Score 21M
Ramy czasowe: 21-Month Follow Up

Change in rTNSS congestion subscore from baseline at the 21-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Congestion. Max score: 3 Min score: 0. Lower values indicate a better outcome.

21-Month Follow Up
rTNSS Rhinorrhea Score 21M
Ramy czasowe: 21-Month Follow Up

Change in rTNSS rhinorrhea subscore from baseline at the 21-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Rhinorrhea. Max score: 3 Min score: 0. Lower values indicate a better outcome.

21-Month Follow Up
rTNSS Nasal Itching Score 21M
Ramy czasowe: 21-Month Follow Up

Change in rTNSS nasal itching subscore from baseline at the 21-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Nasal Itching. Max score: 3 Min score: 0. Lower values indicate a better outcome.

21-Month Follow Up
rTNSS Sneezing Score 21M
Ramy czasowe: 21-Month Follow Up

Change in rTNSS sneezing subscore from baseline at the 21-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Sneezing. Max score: 3 Min score: 0. Lower values indicate a better outcome.

21-Month Follow Up
rTNSS Congestion Score 24M
Ramy czasowe: 24-Month Follow Up

Change in rTNSS congestion subscore from baseline at the 24-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Congestion. Max score: 3 Min score: 0. Lower values indicate a better outcome.

24-Month Follow Up
rTNSS Rhinorrhea Score 24M
Ramy czasowe: 24-Month Follow Up

Change in rTNSS rhinorrhea subscore from baseline at the 24-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Rhinorrhea. Max score: 3 Min score: 0. Lower values indicate a better outcome.

24-Month Follow Up
rTNSS Nasal Itching Score 24M
Ramy czasowe: 24-Month Follow Up

Change in rTNSS nasal itching subscore from baseline at the 24-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Nasal Itching. Max score: 3 Min score: 0. Lower values indicate a better outcome.

24-Month Follow Up
rTNSS Sneezing Score 24M
Ramy czasowe: 24-Month Follow Up

Change in rTNSS sneezing subscore from baseline at the 24-month follow up visit. The Reflective Total Nasal Symptom Score (rTNSS) is a patient-reported outcome questionnaire used to evaluate the severity of nasal symptoms over a recent period of 12 hours. This subscore evaluates Sneezing. Max score: 3 Min score: 0. Lower values indicate a better outcome.

24-Month Follow Up
Total Mini-RQLQ Score 3M
Ramy czasowe: 3-Month Follow Up

Change in total mini-RQLQ score from baseline at the 3-month follow up visit. The Mini Rhinoconjunctivitis Quality of Life Questionnaire (MiniRQLQ) is an abbreviated, 14-item self-administered health status questionnaire designed to measure functional impairments in adults with seasonal or perennial rhinoconjunctivitis. Max Score: 6 Min Score: 0. Lower values indicate a better outcome. Each question is scored 0-6 and the 14 question responses are averaged to create a total score.

3-Month Follow Up
Total Mini-RQLQ Score 6M
Ramy czasowe: 6-Month Follow Up

Change in total mini-RQLQ score from baseline at the 6-month follow up visit. The Mini Rhinoconjunctivitis Quality of Life Questionnaire (MiniRQLQ) is an abbreviated, 14-item self-administered health status questionnaire designed to measure functional impairments in adults with seasonal or perennial rhinoconjunctivitis. Max Score: 6 Min Score: 0. Lower values indicate a better outcome. Each question is scored 0-6 and the 14 question responses are averaged to create a total score.

6-Month Follow Up
Total Mini-RQLQ Score 12M
Ramy czasowe: 12-Month Follow Up

Change in total mini-RQLQ score from baseline at the 12-month follow up visit. The Mini Rhinoconjunctivitis Quality of Life Questionnaire (MiniRQLQ) is an abbreviated, 14-item self-administered health status questionnaire designed to measure functional impairments in adults with seasonal or perennial rhinoconjunctivitis. Max Score: 6 Min Score: 0. Lower values indicate a better outcome. Each question is scored 0-6 and the 14 question responses are averaged to create a total score.

12-Month Follow Up
Total Mini-RQLQ Score 18M
Ramy czasowe: 18-Month Follow Up

Change in total mini-RQLQ score from baseline at the 18-month follow up visit. The Mini Rhinoconjunctivitis Quality of Life Questionnaire (MiniRQLQ) is an abbreviated, 14-item self-administered health status questionnaire designed to measure functional impairments in adults with seasonal or perennial rhinoconjunctivitis. Max Score: 6 Min Score: 0. Lower values indicate a better outcome. Each question is scored 0-6 and the 14 question responses are averaged to create a total score.

18-Month Follow Up
Total Mini-RQLQ Score 21M
Ramy czasowe: 21-Month Follow Up

Change in total mini-RQLQ score from baseline at the 21-month follow up visit. The Mini Rhinoconjunctivitis Quality of Life Questionnaire (MiniRQLQ) is an abbreviated, 14-item self-administered health status questionnaire designed to measure functional impairments in adults with seasonal or perennial rhinoconjunctivitis. Max Score: 6 Min Score: 0. Lower values indicate a better outcome. Each question is scored 0-6 and the 14 question responses are averaged to create a total score.

21-Month Follow Up
Total Mini-RQLQ Score 24M
Ramy czasowe: 24-Month Follow Up

Change in total mini-RQLQ score from baseline at the 24-month follow up visit. The Mini Rhinoconjunctivitis Quality of Life Questionnaire (MiniRQLQ) is an abbreviated, 14-item self-administered health status questionnaire designed to measure functional impairments in adults with seasonal or perennial rhinoconjunctivitis. Max Score: 6 Min Score: 0. Lower values indicate a better outcome. Each question is scored 0-6 and the 14 question responses are averaged to create a total score.

24-Month Follow Up

Współpracownicy i badacze

Tutaj znajdziesz osoby i organizacje zaangażowane w to badanie.

Sponsor

Śledczy

  • Dyrektor Studium: Annalise Sorensen, Neurent Medical

Publikacje i pomocne linki

Osoba odpowiedzialna za wprowadzenie informacji o badaniu dobrowolnie udostępnia te publikacje. Mogą one dotyczyć wszystkiego, co jest związane z badaniem.

Daty zapisu na studia

Daty te śledzą postęp w przesyłaniu rekordów badań i podsumowań wyników do ClinicalTrials.gov. Zapisy badań i zgłoszone wyniki są przeglądane przez National Library of Medicine (NLM), aby upewnić się, że spełniają określone standardy kontroli jakości, zanim zostaną opublikowane na publicznej stronie internetowej.

Główne daty studiów

Rozpoczęcie studiów (Rzeczywisty)

26 września 2022

Zakończenie podstawowe (Rzeczywisty)

5 sierpnia 2025

Ukończenie studiów (Rzeczywisty)

5 sierpnia 2025

Daty rejestracji na studia

Pierwszy przesłany

18 października 2022

Pierwszy przesłany, który spełnia kryteria kontroli jakości

20 października 2022

Pierwszy wysłany (Rzeczywisty)

24 października 2022

Aktualizacje rekordów badań

Ostatnia wysłana aktualizacja (Rzeczywisty)

10 listopada 2026

Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości

16 października 2026

Ostatnia weryfikacja

1 października 2026

Więcej informacji

Terminy związane z tym badaniem

Słowa kluczowe

Inne numery identyfikacyjne badania

  • CIP-0007

Plan dla danych uczestnika indywidualnego (IPD)

Planujesz udostępniać dane poszczególnych uczestników (IPD)?

NIE

Informacje o lekach i urządzeniach, dokumenty badawcze

Bada produkt leczniczy regulowany przez amerykańską FDA

Nie

Bada produkt urządzenia regulowany przez amerykańską FDA

Tak

produkt wyprodukowany i wyeksportowany z USA

Nie

Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .

Subskrybuj